Clinical Trial Update: Efficacy and Safety of Diamel in Patients With Nonalcoholic Steatohepatitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update assessing the efficacy and safety of Diamel in patients with nonalcoholic steatohepatitis and insulin resistance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Nonalcoholic Steatohepatitis

Drugs mentioned

• Diamel

Snippet

Sponsor: Catalysis SL | Conditions: Nonalcoholic Steatohepatitis, Insulin Resistance | Phase 3 | Status: COMPLETED